Timing of bronchiolitis hospitalisations and respiratory syncytial virus immunoprophylaxis in non-metropolitan Western Australia.
Moore
Hannah C
HC
Keil
Anthony D
AD
Richmond
Peter C
PC
Lehmann
Deborah
D
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000008:administration & dosage*; D001990:Bronchiolitis, Viral / Q000517:prevention & control*; D002675:Child, Preschool; D004334:Drug Administration Schedule; D006760:Hospitalization; D006801:Humans; D007223:Infant; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D018113:Respiratory Syncytial Virus, Human; D013997:Time Factors; D014904:Western Australia
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab